Glenmede Trust’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.82M | Buy |
19,041
+294
| +2% | +$28.2K | 0.01% | 611 |
|
|
2026
Q1 | $1.94M | Sell |
18,747
-552
| -3% | -$62.6K | 0.01% | 580 |
|
|
2025
Q4 | $1.95M | Buy |
+19,299
| New | +$2.1M | 0.01% | 573 |
|
|
2025
Q1 | $3.9M | Buy |
26,469
+3,378
| +15% | +$516K | 0.02% | 455 |
|
|
2024
Q4 | $3.75M | Sell |
23,091
-4,977
| -18% | -$814K | 0.02% | 447 |
|
|
2024
Q3 | $4.57M | Buy |
28,068
+14
| +0% | +$2.08K | 0.02% | 451 |
|
|
2024
Q2 | $3.83M | Buy |
28,054
+2,239
| +9% | +$311K | 0.02% | 461 |
|
|
2024
Q1 | $3.95M | Sell |
25,815
-1,775
| -6% | -$265K | 0.02% | 469 |
|
|
2023
Q4 | $3.93M | Sell |
27,590
-1,087
| -4% | -$145K | 0.02% | 454 |
|
|
2023
Q3 | $3.76M | Sell |
28,677
-840
| -3% | -$128K | 0.02% | 432 |
|
|
2023
Q2 | $4.67M | Hold |
29,517
| – | – | 0.03% | 414 |
|
|
2023
Q1 | $4.67M | Sell |
29,517
-424
| -1% | -$63.6K | 0.03% | 414 |
|
|
2022
Q4 | $4.2M | Sell |
29,941
-1,363
| -4% | -$193K | 0.02% | 431 |
|
|
2022
Q3 | $4.02M | Sell |
31,304
-1,718
| -5% | -$248K | 0.03% | 414 |
|
|
2022
Q2 | $4.66M | Sell |
33,022
-1,980
| -6% | -$283K | 0.03% | 409 |
|
|
2022
Q1 | $4.87M | Sell |
35,002
-535
| -2% | -$82K | 0.02% | 418 |
|
|
2021
Q4 | $6.2M | Sell |
35,537
-4,425
| -11% | -$738K | 0.03% | 413 |
|
|
2021
Q3 | $6.62M | Sell |
39,962
-8,962
| -18% | -$1.54M | 0.03% | 385 |
|
|
2021
Q2 | $8.8M | Sell |
48,924
-893
| -2% | -$163K | 0.05% | 355 |
|
|
2021
Q1 | $9.61M | Sell |
49,817
-50,283
| -50% | -$9.68M | 0.05% | 335 |
|
|
2020
Q4 | $20.2M | Buy |
100,100
+3,116
| +3% | +$645K | 0.11% | 219 |
|
|
2020
Q3 | $20.4M | Sell |
96,984
-1,561
| -2% | -$348K | 0.12% | 190 |
|
|
2020
Q2 | $21.6M | Sell |
98,545
-9,261
| -9% | -$1.85M | 0.13% | 191 |
|
|
2020
Q1 | $16.6M | Hold |
107,806
| – | – | 0.08% | 302 |
|
|
2019
Q4 | $16.6M | Sell |
107,806
-10,216
| -9% | -$1.53M | 0.08% | 302 |
|
|
2019
Q3 | $17.9M | Sell |
118,022
-279
| -0.2% | -$44.1K | 0.08% | 285 |
|
|
2019
Q2 | $18.1M | Buy |
118,301
+59,719
| +102% | +$9.12M | 0.08% | 312 |
|
|
2019
Q1 | $9.4M | Buy |
58,582
+1,800
| +3% | +$279K | 0.04% | 380 |
|
|
2018
Q4 | $8.75M | Sell |
56,782
-4,792
| -8% | -$747K | 0.04% | 363 |
|
|
2018
Q3 | $9.26M | Sell |
61,574
-1,750
| -3% | -$249K | 0.04% | 388 |
|
|
2018
Q2 | $8.56M | Sell |
63,324
-1,405
| -2% | -$173K | 0.04% | 379 |
|
|
2018
Q1 | $9.63M | Hold |
64,729
| – | – | 0.04% | 377 |
|
|
2017
Q4 | $9.63M | Buy |
64,729
+194
| +0.3% | +$26.4K | 0.04% | 377 |
|
|
2017
Q3 | $8.51M | Buy |
64,535
+3,516
| +6% | +$472K | 0.04% | 385 |
|
|
2017
Q2 | $8.23M | Hold |
61,019
| – | – | 0.04% | 383 |
|
|
2017
Q1 | $8.23M | Sell |
61,019
-4,595
| -7% | -$595K | 0.04% | 383 |
|
|
2016
Q4 | $7.87M | Sell |
65,614
-189,096
| -74% | -$22.3M | 0.04% | 389 |
|
|
2016
Q3 | $31.9M | Buy |
254,710
+58,635
| +30% | +$7.68M | 0.18% | 187 |
|
|
2016
Q2 | $27.1M | Sell |
196,075
-88,419
| -31% | -$11.5M | 0.16% | 217 |
|
|
2016
Q1 | $35.9M | Buy |
284,494
+215,840
| +314% | +$27.4M | 0.23% | 122 |
|
|
2015
Q4 | $8.71M | Buy |
68,654
+556
| +0.8% | +$69K | 0.06% | 352 |
|
|
2015
Q3 | $7.87M | Sell |
68,098
-3,053
| -4% | -$343K | 0.06% | 362 |
|
|
2015
Q2 | $7.4M | Sell |
71,151
-2,162
| -3% | -$233K | 0.05% | 383 |
|
|
2015
Q1 | $8.09M | Sell |
73,313
-9
| -0% | -$977 | 0.06% | 383 |
|
|
2014
Q4 | $7.64M | Sell |
73,322
-1,024
| -1% | -$102K | 0.06% | 378 |
|
|
2014
Q3 | $7.14M | Sell |
74,346
-63,085
| -46% | -$5.7M | 0.06% | 365 |
|
|
2014
Q2 | $12.6M | Sell |
137,431
-900
| -0.7% | -$80.6K | 0.11% | 261 |
|
|
2014
Q1 | $12.2M | Buy |
138,331
+473
| +0.3% | +$41.5K | 0.11% | 257 |
|
|
2013
Q4 | $12.8M | Buy |
137,858
+2,963
| +2% | +$267K | 0.13% | 218 |
|
|
2013
Q3 | $11M | Buy |
134,895
+6,273
| +5% | +$530K | 0.13% | 203 |
|
|
2013
Q2 | $10.7M | Buy |
+128,622
| New | +$11.1M | 0.13% | 158 |
|
Other funds holding CLX
Glenmede Trust's CLX Position: Q2 2026 in Review
Glenmede Trust increased its Clorox (CLX) stake by 1.6% in Q2 2026, buying an estimated $28.2K and bringing the position to 19,041 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #611.
Glenmede Trust first reported a position in CLX in Q2 2013 and has held it in 51 quarters since. The position peaked at $35.9M in Q1 2016. 1,048 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Glenmede Trust held 19,041 shares of Clorox worth $1.82M as of Q2 2026.
- Glenmede Trust bought 294 Clorox shares in Q2 2026, an estimated $28.2K.
- Clorox made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #611 holding.
- Glenmede Trust first reported a position in Clorox in Q2 2013 and has held it in 51 quarters since.
- Glenmede Trust's Clorox position peaked at $35.9M in Q1 2016.
- 1,048 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.